Alongside resources developed by TB Europe Coalition, ranging from different TBEC publications to various capacity building tools such CSOs map or TBEC webinar recordings, please see below a short overview of different international and regional institutions and organisations, fighting against TB in the WHO Europe region and globally.
All of the websites contain valuable sources of information and capacity building tools that you will find helpful in your advocacy in the WHO Europe region and globally.
Here is a collection of resources that may be of use:
Reports and Case Studies
You can access all previous TB Europe Coalition Newsletters through this page.
Every month the TB Europe Coalition produces and disseminates an email newsletter to our entire membership. The newsletter is written so as to inform our membership, those working on TB and related issues, about civil society activities, policy and resource developments, and any other information that could be used to help with capacity building in the region.
For access to the newsletter archive from February 2014 – February 2015 please click here.
- TBEC – REG webinar series TB and Migrant Health:
- First webinar (EECA) recording and presentation (03/03)
- Second webinar (Western Europe) recording and presentation (20/04)
- Third Webinar (Panel Discussion) recording (21/05)
- Demanding a Higher Standard of TB Care in Eastern Europe and Central Asia (EECA) recording and presentation
- TBEC Webinar series on the Impact of COVID-19 on TB R&D:
- Vaccine webinar recording and presentation (28/09)
- Recording and presentation on the TB Vaccine Pipeline
- Recording and presentation on The Broad Benefits of TB Vaccine Research
- Vaccine webinar recording and presentation (28/09)
-
- Diagnostics webinar recording and presentation (02/10)
- Recording and presentation on Diagnostics Policy and Practice
- Recording and presentation on the TB Diagnostic Pipeline
- Recording and presentation on R&D policy reform – From TB to Covid-19
- Diagnostics webinar recording and presentation (02/10)
-
- Treatment webinar recording and presentation (07/10)
- Recording and presentation on Impact of COVID-19 on TB Drug Development
- Recording and presentation on Community Involvement in R&D
- Treatment webinar recording and presentation (07/10)
- TBEC webinar series on the 2020-2022 Global Allocation Cycle:
- First webinar recording and presentation (30/04)
- Second webinar recording and presentation (15/05)
- Third webinar recording and presentation (26/06
- TBEC Webinar on Advocating for Drug-Resistant TB Treatment (Russian/English)
- TBEC webinar on advocating for new DR-TB treatment regimes – recording and presentation (10/2019)
- TBEC webinar on parliamentary engagement in RU – recording and presentation (04/2019) (in partnership with the Global TB Caucus and with technical support from the EECA platform)
- TBEC webinar on resource mobilisation and partnership building – recording and presentation (02/2019)
- TBEC webinar on the Global Fund CRG Technical Assistance program in RU (11/12/2018)
- TBEC webinar on STC of Health Products (06/2018)
- TBEC webinar on STC of Health Products (Part 1) (06/2018)
- TBEC webinar on STC of Health Products (Part 2) (06/2018)
- TBEC webinar on STC of Health Products (Part 3) (06/2018)
- TBEC webinar on STC of Health Products (Part 4) (06/2018)
- TBEC webinar on global and in-country advocacy ahead of UN HLM on TB (05/2018)
- TBEC webinar on UN High Level Meeting on TB (09/2017)
- TBEC webinar on media engagement (09/2017)
- TBEC webinar on Global TB Caucus (12/2016)
- TBEC webinar on EU funding (10/2016)
Transition to People-Centred Model of TB Care: Role of Civil Society and Affected Community
What Happens Next: Accountability Post UN High Level Meeting On TB
Resource Mobilisation Building Partnerships: A Practical Guide
Transitioning From Donor Support For TB & HIV in Europe: Georgia
Transitioning From Donor Support For TB & HIV in Europe: Estonia
Transitioning From Donor Support For TB & HIV in Europe: Bulgaria
Tuberculosis – The Cornerstone of The AMR Threat
Moving To People-Centred Care: Achieving better TB outcomes
A guide to working with parliamentarians
How to leverage European union funding for health in eastern Europe & Central Asia
Transitioning From Donor Support For TB & HIV in Eastern Europe & Central Asia
After Aid: What is next for Tuberculosis & HIV in Europe?
Tuberculosis: Voices in The Fight Against the European Epidemic
This page provides information on the latest funding opportunities available to countries in the region. For a quick guide to some of the key funding partners in the region please see our Fundraising Handout or below.
Funding from the Stop TB Partnership
One key area of the work of the Stop TB Partnership is to provide technical support to the process of developing stronger concept notes and country dialogues to increase the chances of getting funded.
The Challenge Facility for Civil Society (CFCS) is an instrument to promote the role of communities in National TB Programmes, and on other high-level platforms, especially in countries supported by the Global Fund.
TB REACH was launched in January 2010 with multi-year grant support from the Canadian International Development Agency. TB REACH provides short-term and fast track grants to projects that aim to achieve early and increased TB case detection using innovative approaches in populations that are poor and vulnerable and have limited access to care.
Stop TB Partnership awards Kochon Prize annually to individuals and/or organizations that have made a significant contribution to combating TB. The Kochon Prize, which is endowed by the Kochon Foundation, a non-profit foundation registered in the Republic of Korea, consists of a USD $65,000 award.
USAID have several grant programmes that may prove fruitful. For example, the Development Grants Program that seeks to support NGOs that have limited or no experience working directly with USAID, and to strengthen the capacity of these organisations.
Funding from the European Union
European Union: NGOs, CSOs and community based organisations are eligible for a EU funding, as they are involved in many areas covered by EU policies on a non-profit basis, a precondition for receiving funding from EU coffers. This includes issues around health. Funding is available both under direct access programmes run by the Commission as under programmes financed through structural funds, and available at the regional authorities. There will be an EU delegation in your country and so we would recommend getting in touch with them.
To learn more about EU funding in your country, please read our brief.
GIZ – German BACKUP Initiative
Germany: since 2002, the global health programme German BACKUP Initiative has been assisting applicant countries in using Global Fund grants more effectively and efficiently. The initiative was commissioned by the German Federal Ministry for Economic Cooperation and Development (BMZ) and has been co-funded by the Swiss Agency for Development and Cooperation (SDC) since 2013.
TBEC works with a variety of partners. For more information, follow the links below
European Harm Reduction Association
Eurasian Coalition on Health, Rights, Gender and Sexual Diversity
SWAN – Sex Workers’ Rights Advocacy Network.
Eurasian Women’s Network on AIDS
International Treatment Preparedness Coalition in Eastern Europe and Central Asia
Альянс громадського здоров’я Alliance for Public Health
- UN High-Level Meeting on TB Key Targets & Commitments for 2022 (Stop TB Partnership, 2018)
- Political Declaration of the UN General Assembly High-Level Meeting (WHO 2018)
A global document to that summarizes countries’ commitment to end TB by 2030 according to the Sustainable Development Goals. - The END TB Strategy (2016 –2020)
- United Nations common position on ending HIV, TB and viral hepatitis through intersectoral collaboration (WHO 2018)
- Tuberculosis action plan for the WHO European Region 2016–2020 (WHO 2016)
- Declaration of the rights of people affected by tuberculosis (StopTB 2019)
- Know Your Rights: Tuberculosis Prevention, Diagnosis, and Treatment (Treatment Action Group 2019)
- WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment (WHO 2019)
- Rapid Communication: Key changes to treatment of multidrug-and rifampicin-resistant tuberculosis (MDR/RR-TB) (WHO 2018)
- Compendium of WHO guidelines and associated standards: ensuring optimum delivery of the cascade of care for patients with tuberculosis(Eng) (WHO 2018)
- Compendium of good practices in the implementation of the Tuberculosis Action Plan for the WHO European Region 2016–2020 (Eng) (WHO 2019)
- Ambulatory care and infectiousness in tuberculosis (WHO 2018)
- Guiding Principles to Reduce Tuberculosis Transmission in the WHO European Region (WHO 2018)
STOP TB Partnership key population briefs
- Children: (StopTB)
- Miners: (StopTB)
- Mobile populations: (StopTB)
- People who use drugs: (StopTB)
- Prisoners: (StopTB)
- Rural populations: (StopTB)
- Urban populations: (StopTB)
- Health care workers: (StopTB)
- People living with HIV (StopTB)
STOP TB Stigma Assessment -Implementation Handbook (StopTB 2019)
STOP TB Stigma Assessment -Data Collection Instruments (StopTB 2019)
Communities, Rights and Gender TB Tools Assessments In Ukraine (StopTB 2018)
- Empowering communities to end TB with the ENGAGE-TB approach, WHO publications on community engagement: (WHO 2018)
- An Activists Guide to Bedaquiline
This guide summarizes updated efficacy, safety, and access information about bedaquiline, an essential medication in the treatment of multidrug-resistant TB (MDR-TB). - TB Drug Research Literacy Toolkit (TB Alliance 2014)
A toolkit that has been used to traincommunity members at local sites on key concepts in product development. The kit is available and can be a resource for those working in TB research to help educate and inform stakeholders. - Social Accountability of Government Institutions (ECOM, 2019):